1. Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young ME, et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am J Physiol Endocrinol Metab 2013; 305: E243-53.
2. Koleini N and Kardami E. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity. Oncotarget 2017; 8(28): 46663-80.
3. Singal P, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart failure: mechanisms and modulation. Mole Cell Biochem 2000; 207(1-2): 77-86.
4. Cadete VJ, Deschenes S, Cuillerier A, Brisebois F, Sugiura A, Vincent A, et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system. J Physiol 2016; 594: 5343-62.
5. Ebadi B, Damirchi A. Effect of exercise training intensity on mitochondrial dynamics and mitophagy in post myocardial infarction rat. Int J Appl Exrc Physiol 2018; 7(2): 2322-3537.
6. Kavazis AN, Smuder AJ, Powers SK. Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle. J Appl Physiol 2014; 117(3): 223–30.
7. Dolinsky VW, Rogan KJ, Sung MM, Zordoky B.N, Haykowsky MJ, Young ME, et al. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice. Am J Physiol Endocrinol Metab 2013; 305: E243-253.
8. Marques-Aleixo I, Santos-Alves E, Mariani D, Rizo-Roca D, Padrão AI, RochaRodrigues S, et al. Physical exercise prior and during treatment reduces subchronic doxorubicin-induced mitochondrial toxicity and oxidative stress. Mitochondrion 2015; 20: 22–33.
9. Smuder AJ, Kavazis AN, Min K, Powers SK. Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals. J Appl Physiol 2013; 115: 176-85.
10. Gibala MJ, Jones AM. Physiological and performance adaptations to high-intensity interval training. Nestle Nutr Inst Workshop Ser 2013; 76: 51–60.
11. Macinnis MJ, Gibala MJ. Physiological adaptations to interval training and the role of exercise intensity. J Physiol 2017; 595(9): 2915–30.
12. Ebrahimi Kh, Choobineh S, Badalzadeh R, Soori R. Protective Effect of Aerobic High-Intensity Interval Training Against Doxorubicin-Induced Cardiotoxicity in Rats. J Know Heal 2018; 13(1). [in Persian]
13. Fan SH, Zhang ZF, Zheng YL, Lu J, Wu DM, Shan Q, et al. Troxerutin protects the mouse kidney from d-galactose-caused injury through antiinflammation and anti-oxidation. Int Immunopharmaco 2009; 9(1): 91-6.
14. Sarkar A, Biswas N, Kapoor S, Mahal HS, Nair CKK and Mukherjee T. One-electron redox reactions of troxerutin in aqueous solutions. Res Chem Interme 2005; 31(9): 857-866.
15. Gohel MS, Davies AH. Pharmacological agents in the treatment of venous disease: an update of the available evidence. Cur Vascu Pharmaco 2009; 7(3): 303-8.
16. Taghavi Holagh A, Abed Natanzi H, Badalzadeh R, Ghazalian F. The synergistic effect of high-intensity interval training and troxerotin on heart injury and mitochondrial function in doxorubicin-induced cardiac toxicity. J Know Heal 2020; 15(3): 46-53. [in Persian]
17. Taghavi Holagh A, Abed Natanzi H, Badalzadeh R, Ghazalian F. The effect of Troxerutin combined with high intensity interval training on heart injury and expression of antioxidant genes in doxorubicin-induced cardiac toxicity in male rats. Daneshvar Med 2021; 29(2): 78-89. [in Persian]
18. Haram PM, Kemi OJ, Lee SJ, Bendheim M, Al-Share QY, Waldum HL, et al. Aerobic interval training vs. continuous moderate exercise in the metabolic syndrome of rats artificially selected for low aerobic capacity. Cardiovasc Res 2009; 81(4): 723-32.
19. Babri S, Amani M, Mohaddes G, Alihemmati A, Ebrahimi H. Protective effects of troxerutin on β-amyloid (1-42)-induced impairments of spatial learning and memory in rats. Neurophy 2012; 44(5): 387-93.
20. Hoydal MA, Wisloff U, Kemi OJ, Ellingsen O. Running speed and maximal oxygen uptake in rats and mice: Practical implications for exercise training. Eur J Cardiovasc Prev Rehabil 2007; 14(6): 753–60.
21. Ascensão A, Magalhães J, Soares JM, Ferreira R, Neuparth MJ, Marques F, et al. Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis. Am J Physiol-Heart Circul Physiol 2005; 289(2): 722-31.
22. Asadi M, Shanehbandi D, Mohammadpour H, Hashemzadeh S, Sepehri B. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma. J Gastroint cancer 2018; 1-4.
23. Zhou S, Starkov A, Froberg MK, Leino RL, Wallace KB. Cumulative and Irreversible Cardiac Mitochondrial Dysfunction Induced by Doxorubicin. Cancer Res 2001; 61(2): 771–7.
24. Shirinbayan V, Roshan VD. Pretreatment effect of running exercise on HSP70 and DOXinduced cardiotoxicity. Asian Pac J Cancer Prev 2012; 13: 5849-55.
25. Ebrahimi KH, Choobineh S, Soori R and Badalzadeh R. Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats. J Clin Res Paramed Sci 2019; 8(1): e83850.
26. Jarrett CL, D’Lugos AC, Mahmood TN, Gonzales RJ, Hale TM, Carroll CC, et al. Effect of high intensity exercise preconditioning and training on antioxidant enzymes in cardiomyocytes during doxorubicin treatment. FASEB J 2016; 30 (Suppl 1): lb601.
27. Heidarzadeh F, Badalzadeh R and Hatami H. The effect of troxerutin on lipid peroxidation and tissue injury induced by myocardial ischemia reperfusion injury in diabetic rat. Razi J Med Sci 2014; 21(125): 37-45. [in Persian]
28. Drake JC, Wilson RJ, Yan Z. Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J 2016; 30(1): 13-22.
29. Jiang HK, Miao Y, Wang YH, Zhao M, Feng ZH, Yu XJ, et al. Aerobic interval training protects against myocardial infarction‐induced oxidative injury by enhancing antioxidase system and mitochondrial biosynthesis. Cli Expe Pharmacol Physiol 2014; 41(3): 192-201.
30. Ascensão A, Ferreira R, Oliveira PJ, Magalhães J. Effects of endurance training and acute Doxorubicin treatment on rat heart mitochondrial alterations induced by in vitro anoxia-reoxygenation. Cardiovasc Toxicol 2006; 6(3-4): 159-72.